Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2009 Aug;94(8):1041-3.
doi: 10.3324/haematol.2009.007682.

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome

Mario Cazzola
Editorial

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome

Mario Cazzola. Haematologica. 2009 Aug.

Abstract

In this perspective article, Dr. Cazzola examines standard and novel tools for the diagnosis of myelodysplastic syndrome. Flow cytometry immunophenotyping may provide complementary information in the diagnostic approach to a patient with this condition. See related articles on pages 1066, 1124 and 1160.

PubMed Disclaimer

Comment on

References

    1. Cazzola M, Malcovati L. Myelodysplastic syndromes--coping with ineffective hematopoiesis. N Engl J Med. 2005;352:536–8. - PubMed
    1. Bergamaschi G, Markopoulos K, Albertini R, Di Sabatino A, Biagi F, Ciccocioppo R, et al. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica. 2008;93:1785–91. - PubMed
    1. Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica. 2008;93:1712–7. - PubMed
    1. Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C, et al. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol. 2009;27:754–62. - PubMed
    1. Bennett JM, Orazi A. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach. Haematologica. 2009;94:264–8. - PMC - PubMed

MeSH terms